Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
2020 · The American Journal of Human Genetics · 64 citations
https://doi.org/10.1016/j.ajhg.2020.09.001
I
Iris Kramer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
523
Citations
7
h-index
7
i10-index
Iris Kramer is an academic researcher from Trimbos Institute. The author has contributed to research in topics: Breast Cancer Treatment Studies & BRCA gene mutations in cancer & Global Cancer Incidence and Screening. The author has an h-index of 7, co-authored 19 publications.
ORCID: 0000-0002-0747-3762Papers by this author
worksPrediction and clinical utility of a contralateral breast cancer risk model
2019 · Breast Cancer Research · 38 citations
https://doi.org/10.1186/s13058-019-1221-1
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
2020 · npj Breast Cancer · 14 citations
https://doi.org/10.1038/s41523-020-00202-8
Data and metadata supporting the published article: Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
2020 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.12982424
MOESM1 of Prediction and clinical utility of a contralateral breast cancer risk model
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.11393661
MOESM2 of Prediction and clinical utility of a contralateral breast cancer risk model
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.11393673
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat